[Back]
Assoz. Prof. Mag. Dr. Verena Pichler
T: +43-1-4277-55624
41 - 60 out of 99
Bauer M, Barna S, Blaickner M, Prosenz K, Bamminger K, Pichler V et al. Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [11C]Metoclopramide. Molecular Imaging and Biology. 2021 Apr;23:180-185. doi: 10.1007/s11307-021-01582-4
Bauer M, Bamminger K, Pichler V, Weber M, Binder S, Maier-Salamon A et al. Impaired clearance from the brain increases the brain exposure to metoclopramide in elderly subjects. Clinical Pharmacology and Therapeutics. 2021 Mar;109(3):754-761. Epub 2020 Sept 23. doi: 10.1002/cpt.2052
Mayerhoefer ME, Raderer M, Lamm W, Pichler V, Pfaff S, Weber M et al. CXCR4 PET imaging of mantle cell lymphoma using [68Ga]Pentixafor: Comparison with [18F]FDG-PET. Theranostics. 2021;11(2):567-578. doi: 10.7150/thno.48620
Sauerzopf U, Weidenauer A, Dajic I, Bauer M, Bartova L, Meyer B et al. Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia. NeuroImage: Clinical. 2021;32:102813. doi: 10.1016/j.nicl.2021.102813
Calabretta R, Hoeller C, Pichler V, Mitterhauser M, Karanikas G, Haug A et al. Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries. Circulation. 2020 Dec 15;142(24):2396–2398. doi: 10.1161/CIRCULATIONAHA.120.048708
Ozenil M, Aronow J, Piljak D, Vraka C, Holzer W, Spreitzer H et al. Synthesis, Biological, and Computational Evaluation of Antagonistic, Chiral Hydrobenzoin Esters of Arecaidine Targeting mAChR M1. Pharmaceuticals. 2020 Nov 30;13(12):1-12. 437. doi: 10.3390/ph13120437
Ozenil M, Pacher K, Balber T, Vraka C, Roller A, Holzer W et al. Enhanced arecoline derivatives as muscarinic acetylcholine receptor M1 ligands for potential application as PET radiotracers. European Journal of Medicinal Chemistry. 2020 Oct 15;204:112623. doi: 10.1016/j.ejmech.2020.112623
Klebermass EM, Mahmudi M, Miller A, Pichler V, Vraka C, Balber T et al. 2-[F-18]FDG metabolism: The role of alternative metabolic pathways. European Journal of Nuclear Medicine and Molecular Imaging. 2020 Sept;47(Suppl 1):S12-S13. OP-022. doi: 10.1007/s00259-020-04988-4
Mayerhoefer ME, Haug A, Jäger U, Pichler V, Pfaff S, Wester HJ et al. In Human Visualization of Ibrutinib-Induced CLL Compartment Shift. Cancer immunology research. 2020 Aug;8(8):984-989. doi: 10.1158/2326-6066.CIR-19-0880
Baldinger-Melich P, Gryglewski G, Philippe C, Murgaš M, James GM, Vraka C et al. Corrigendum to "The effect of electroconvulsive therapy on cerebral monoamine oxidase a expression in treatment-resistant depression investigated using positron emission tomography" [Brain Stimul 12 (3) (2019) 714-723]. Brain Stimulation. 2020 Jun 26;13(5):1280-1281. doi: 10.1016/j.brs.2020.06.009
Unterholzner J, Gryglewski G, Philippe C, Seiger R, Pichler V, Godbersen GM et al. Topologically Guided Prioritization of Candidate Gene Transcripts Coexpressed with the 5-HT1A Receptor by Combining in Vivo PET and Allen Human Brain Atlas Data. Cerebral Cortex. 2020 May 18;30(6):3771-3780. doi: 10.1093/cercor/bhz341
Hahn A, Breakspear M, Rischka L, Wadsak W, Godbersen GM, Pichler V et al. Reconfiguration of functional brain networks and metabolic cost converge during task performance. eLife. 2020 Apr 21;9:e52443. doi: 10.7554/eLife.52443
Rasul S, Geist BK, Brath H, Baltzer P, Sundar LKS, Pichler V et al. Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using 18F-FDG PET/MRI. BMJ open diabetes research & care. 2020 Mar;8(1):e001135. doi: 10.1136/bmjdrc-2019-001135
Beitzke D, Rasul S, Lassen ML, Pichler V, Senn D, Stelzmüller ME et al. Assessment of Myocardial Viability in Ischemic Heart Disease by PET/MRI: Comparison of Left Ventricular Perfusion, Hibernation, and Scar Burden. Academic radiology. 2020 Feb;27(2):188-197. doi: 10.1016/j.acra.2019.03.021
Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S et al. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study. Translational Psychiatry. 2020 Jan 8;10(1):2. doi: 10.1038/s41398-019-0681-5
Beitzke D, Wielandner A, Wollenweber T, Vraka C, Pichler V, Uyanik-Uenal K et al. Assessment of sympathetic reinnervation after cardiac transplantation using hybrid cardiac PET/MRI: A pilot study. Journal of magnetic resonance imaging : JMRI. 2019 Oct;50(4):1326-1335. doi: 10.1002/jmri.26722
Silberbauer LR, Gryglewski G, Berroterán-Infante N, Rischka L, Vanicek T, Pichler V et al. Serotonin transporter binding in the human brain after pharmacological challenge measured using PET and PET/MR. Frontiers in molecular neuroscience. 2019 Jul 12;12:172. doi: 10.3389/fnmol.2019.00172
Tournier N, Bauer M, Pichler V, Nics L, Klebermass EM, Bamminger K et al. Impact of P-glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans. The Journal of Nuclear Medicine. 2019 Jul 1;60(7):985-991. Epub 2019 Jan 10. doi: 10.2967/jnumed.118.219972
Gryglewski G, Klöbl M, Berroterán-Infante N, Rischka L, Balber T, Vanicek T et al. Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging. European Neuropsychopharmacology. 2019 Jun;29(6):711-719. doi: 10.1016/j.euroneuro.2019.04.001
Pfaff S, Philippe C, Nics L, Berroteran-Infante N, Pallitsch K, Rami-Mark C et al. Facilitated troubleshooting in (+)-[C-11]PHNO synthesis by investigation of reagents, byproducts, and intermediates. Journal of Labelled Compounds and Radiopharmaceuticals. 2019 May;62:255-257.
41 - 60 out of 99

Sanggenons for inhalation? Biopharmaceutical profiling of anti-infectives from Morus alba root bark

Sigrid Adelsberger (Speaker), Jacqueline Schwarzinger (Contributor), Karin Ortmayr (Contributor), Sarah Stellnberger (Contributor), Ammar Tahir (Contributor), Gabriela Hädrich (Contributor), Verena Pichler (Contributor), Judith Maria Rollinger (Contributor), Lea Ann Dailey (Contributor) & Ulrike Grienke (Contributor)

4 Jul 2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Back-to-basics II: Computational methods in radio-pharmaceutical sciences

Verena Pichler (Speaker)

2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

The beautiful world of radiopharmaceuticals

Verena Pichler (Speaker)

2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Research Club, Accumulation of micro- and nanoplastic in colorectal cancer cells

Verena Pichler (Speaker)

13 Dec 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

How to label micro- and nanoplastic

Verena Pichler (Speaker)

27 Sept 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Lecture: Medicinal Radiochemistry

Verena Pichler (Speaker)

17 May 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

FFG Project Spheriograph, Dynamic 3D cell culture method

Verena Pichler (Speaker)

2 May 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Strategies for 18-Fluorine labelling of exendin-4

Verena Pichler (Speaker)

1 Mar 2022

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Isotopes' Availability

Verena Pichler (Speaker)

22 Oct 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

First-in-human brain imaging of the GluN2B-containing N-methyl-D-aspartate receptor with (R)-11C-Me-NB1 PET

Lucas Rischka (Speaker), Chrysoula Vraka (Contributor), Verena Pichler (Contributor), Sazan Rasul (Contributor), Lukas Nics (Contributor), Gregor Gryglewski (Contributor), Patricia A. Handschuh (Contributor), Matej Murgaš (Contributor), G. N. Godbersen (Contributor), Leo Silberbauer (Contributor), M. Unterholzner (Contributor), C. Wotawa (Contributor), A. Haider (Contributor), H. Ahmed (Contributor), Roger Schibli (Contributor), Thomas Mindt (Contributor), Markus Mitterhauser (Contributor), Wolfgang Wadsak (Contributor), A. Hahn (Contributor), Rupert Lanzenberger (Contributor), Markus Hacker (Contributor) & Simon M. Ametamey (Contributor)

20 Oct 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Imaging Probes based on Small Molecules with Emphasis on PET

Verena Pichler (Speaker)

24 Aug 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Quantification of radiotracer accumulation in a dynamic column-based 3D cell culture

Verena Pichler (Speaker)

17 May 2021

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Differences and similarities between symmetrically and unsymmetrically substituted PtIV complexes with N,(N)-(di)alkylethane-1,2-diamine ligands

Verena Pichler (Speaker)

8 Sept 2013

Activity: Talks and presentations › Talk or oral contribution › Other

Department of Pharmaceutical Sciences

Strahlenschutzbeauftragte

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2E306

T: +43-1-4277-55624

verena.pichler@univie.ac.at